Deutsche Bank Ag\ Stoke Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 462,475 shares of STOK stock, worth $5.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

462,475

Previous 16,030 2785.06%

Holding current value

$5.14 Million

Previous $216,000 2531.02%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$12.24 - $15.92 $5.46 Million - $7.11 Million	446,445 Added 2785.06%	462,475 $5.68 Million
Q2 2024 Aug 14, 2024	SELL	$11.03 - $17.52 $4.37 Million - $6.94 Million	-396,210 Reduced 96.11%	16,030 $216,000
Q1 2024 May 15, 2024	SELL	$4.12 - $14.17 $2,216 - $7,623	-538 Reduced 0.13%	412,240 $5.57 Million
Q4 2023 Feb 14, 2024	BUY	$3.37 - $5.4 $1.34 Million - $2.15 Million	399,016 Added 2899.4%	412,778 $2.17 Million
Q3 2023 Nov 09, 2023	SELL	$3.78 - $11.99 $2.1 Million - $6.68 Million	-556,749 Reduced 97.59%	13,762 $54,000
Q2 2023 Aug 14, 2023	SELL	$7.93 - $13.82 $1.16 Million - $2.02 Million	-146,406 Reduced 20.42%	570,511 $6.06 Million
Q1 2023 May 15, 2023	SELL	$7.65 - $10.38 $236,147 - $320,420	-30,869 Reduced 4.13%	716,917 $5.97 Million
Q4 2022 Feb 13, 2023	SELL	$7.07 - $15.69 $276,429 - $613,463	-39,099 Reduced 4.97%	747,786 $6.9 Million
Q3 2022 Nov 14, 2022	SELL	$12.56 - $22.53 $18,789 - $33,704	-1,496 Reduced 0.19%	786,885 $10.1 Million
Q2 2022 Aug 11, 2022	BUY	$10.36 - $23.93 $5.35 Million - $12.4 Million	516,495 Added 189.97%	788,381 $10.4 Million
Q1 2022 May 13, 2022	BUY	$17.19 - $26.1 $4.26 Million - $6.46 Million	247,555 Added 1017.45%	271,886 $5.72 Million
Q4 2021 Feb 11, 2022	SELL	$18.11 - $30.72 $51,867 - $87,982	-2,864 Reduced 10.53%	24,331 $584,000
Q3 2021 Nov 04, 2021	BUY	$23.65 - $34.44 $345,952 - $503,788	14,628 Added 116.4%	27,195 $693,000
Q2 2021 Aug 11, 2021	BUY	$30.53 - $41.09 $106,824 - $143,773	3,499 Added 38.59%	12,567 $423,000
Q1 2021 May 13, 2021	SELL	$36.08 - $69.81 $5,087 - $9,843	-141 Reduced 1.53%	9,068 $352,000
Q4 2020 Feb 16, 2021	BUY	$33.62 - $61.93 $83,175 - $153,214	2,474 Added 36.73%	9,209 $570,000
Q3 2020 Nov 12, 2020	BUY	$22.23 - $37.48 $13,115 - $22,113	590 Added 9.6%	6,735 $225,000
Q2 2020 Aug 13, 2020	BUY	$20.26 - $29.73 $4,761 - $6,986	235 Added 3.98%	6,145 $146,000
Q1 2020 May 14, 2020	BUY	$16.8 - $34.15 $44,671 - $90,804	2,659 Added 81.79%	5,910 $135,000
Q4 2019 Feb 14, 2020	BUY	$20.01 - $30.79 $8,524 - $13,116	426 Added 15.08%	3,251 $91,000
Q3 2019 Nov 14, 2019	BUY	$20.53 - $37.72 $57,997 - $106,559	2,825 New	2,825 $59,000

Others Institutions Holding STOK

# of Institutions

124

Shares Held

57.6M

Call Options Held

9.3K

Put Options Held

35.2K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $438M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account